Biotech News

Charles River Laboratories to Acquire Frontage’s Bioanalysis and DMPK Businesses

Charles River (CRL)Charles RiverCompany update

– Strengthens Charles River's Bioanalysis and DMPK Capabilities to Support Clients Across the Drug Development Lifecycle – – Advances Pathway to Purpose Strategy and Enhances Long-Term Growth and Value Creation – WILMINGTON, Mass. --(BUSINESS WIRE)--Nov.

Related news

Charles River

Preclinical Research Services Charles River Laboratories provides products and outsourced services used by pharmaceutical, biotechnology, academic and government researchers across early drug development. Research Models and Services The company supplies research models and related services used in basic research, target validation and...

Recent company news

Stock data

Close
327.93 USD
Market cap
8.42B USD
Exchange
NYSE
Sector
Biopharma
Location
United States